GlassScriptPhysician profile
Chantel T Jacobs
NPI 1821476458
$3,898.31
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $624 · 2021: $1,336 · 2022: $806 · 2023: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $620.86 | 2019-2022 | |
| Lilly USA, LLC | $475.63 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Takeda Pharmaceuticals U.S.A., INC. | $438.66 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $392.36 | 2019-2023 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $269.53 | 2020-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $235.90 | 2019-2021 | |
| Amgen INC. | $222.39 | 2019-2023 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.23 | 2021-2022 | |
| Pfizer INC. | $183.62 | 2019-2023 | |
| Abbvie INC. | $176.94 | 2021-2023 | |
| Intuitive Surgical, INC. | $98.62 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.98 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $77.24 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.91 | 2022 | |
| Medtronic, INC. | $50.97 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $35.89 | 2019 | |
| Radius Health, INC. | $35.75 | 2023 | Tymlos |
| Eisai INC. | $33.85 | 2020 | |
| Bausch Health US, LLC | $33.32 | 2020-2021 | |
| Phadia US INC. | $31.09 | 2019-2021 | |
| Astellas Pharma US INC | $22.23 | 2023 | Veozah |
| Paratek Pharmaceuticals, INC. | $21.11 | 2021 | |
| Allergan, INC. | $16.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.49 | 2020 | |
| Ibsa Pharma INC. | $16.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chantel Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.